Literature DB >> 31081936

Catechol O-Methyltransferase Pharmacogenomics: Challenges and Opportunities.

Ming-Fen Ho1, Richard M Weinshilboum1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31081936      PMCID: PMC6663608          DOI: 10.1002/cpt.1452

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Enzymatic O-methylation of epinephrine and other catechols.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

2.  Augmentation of Physician Assessments with Multi-Omics Enhances Predictability of Drug Response: A Case Study of Major Depressive Disorder.

Authors:  Arjun Athreya; Ravishankar Iyer; Drew Neavin; Liewei Wang; Richard Weinshilboum; Rima Kaddurah-Daouk; John Rush; Mark Frye; William Bobo
Journal:  IEEE Comput Intell Mag       Date:  2018-07-20       Impact factor: 11.356

3.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

Authors:  H M Lachman; D F Papolos; T Saito; Y M Yu; C L Szumlanski; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  1996-06

4.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.

Authors:  J Tenhunen; M Salminen; K Lundström; T Kiviluoto; R Savolainen; I Ulmanen
Journal:  Eur J Biochem       Date:  1994-08-01

5.  Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.

Authors:  R M Weinshilboum; F A Raymond
Journal:  Am J Hum Genet       Date:  1977-03       Impact factor: 11.025

  5 in total
  2 in total

1.  Pharmacogenetics: Chasing Perfection.

Authors:  Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2019-08       Impact factor: 6.875

Review 2.  Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction.

Authors:  Thanh Thanh L Nguyen; Duan Liu; Ming-Fen Ho; Arjun P Athreya; Richard Weinshilboum
Journal:  Front Pharmacol       Date:  2021-01-11       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.